ArticleMedical oncology (Northwood, London, England)2009

Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor.

B Linderholm et al.PubMed ↗Publisher ↗

No numbers read from the abstract.